Costs and Benefits of Measles Vaccination in Finland

Abstract

Measles vaccination is fairly beneficial. During the third year after launching of the vaccination programme, cumulative benefits accruing from vaccination outweigh the cumulative costs of vaccination. This conclusion is based on a study of the vaccination programme in Finland. According to the vaccination programme, all 1-year-old infants in Finland are vaccinated. The duration of the period under survey has been set at 25 years, the measuring unit is the Finnish mark and the price level is that of the year 1975. When comparing costs and benefits, these are converted to present day monetary values. Vaccination costs per vaccinated infant amount to 32 marks, and in total during the period 1975–1999 they will amount to about 34 million marks according to an interest rate of 9% and to about 41 million marks according to an interest rate of 6% in current monetary value. Benefits gained by vaccination, compared with costs, are manifold. The benefits of one vaccination have been estimated at 230 marks. In total, benefits during the period 1975–99 constitute ca 117 million marks at an interest rate of 9%, and ca 159 million marks at an interest rate of 6% in current monetary value, without any deduction for vaccination costs. The net gain of vaccination—with a deduction of vaccination costs—is ca 84 million marks at an interest rate of 9%, and ca 118 million marks at an interest rate of 6% in current monetary value.

Get full access to this article

View all access options for this article.

References

1. Barkin, R. M. :Measles mortality. Analysis of the primary cause of death. Am J Dis Child 129: 307, 1975.

2. La Boccetta, A. C. & Tornay, A. S. :Measles encephalitis. Report of 61 cases. Am J Dis Child 105: 247, 1964.

3. Elo, O. : (a) Vihurirokon kustannus-hyötyanalyysi. (Cost-benefit analysis of rubella vaccination.) Sosiaalilääketieteellinen Aikakauslehti 11, Suppl. 1, 1974.

3.b Suomen rokotuspolitiikan suuntaviivoja (Outlines of Finnish vaccination policy.) Hallinto ja Terveys. 1:21 1974.

4. Elo, O., Laurinkari, J. & Niemelä, P.: Vihurirok-korokotuksen kustannushyötyanalyysi. Tampereen yliopiston kansanterveystieteen laitos, Julkaisusarja A. Tutkimuksia ja selvityksiä no 4. Tampere, 1974. (Cost-benefit analysis of rubella vaccination. Institute of Public Health Science of the University of Tampere. Publication Series A. Studies and Surveys no 4, Tampere, 1974.

5. Grubb, R. , Hedlund, P. , Lagercranz, R. , Lundbäck, H. , Norrby, E. & Svedmyr, A. :Skälen att rekom-mendera mässlingsvaccination i Sverige. (Reasons for recommending measles vaccination in Sweden.). Läkartidningen 69: 702, 1972.

6. Holmgren, R. , Karsten, S.-O. , Lindahl & Sterner G. :Mässlingskomplikationer. Analys av ett sjukhusmaterial. (Complications relating to measles. Analysis of a hospital material.) Läkartidningen 64: 1088, 1967.

7. Honwitz, O. , Grunfeld, K. , Lysgaard-Hansen, B. & Kjeldsen, K. :The epidemiology and natural history of measles in Denmark. Am J Epidemiol 100: 136, 1974.

8. Jabbour, J. T., Duenas, D. A., Sever, J. L., Krebs, H. M. & Horta-Barbosa: Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE registry. Presented in part at the Academy of Neurology, New York, 1971.

10.

9. Krugman, S. :Present status of measles and rubella immunization in the United States. A medical progress report. Pediatrics 78: 1, 1971.

11.

10. Mattson, B.: Samhällsekonomiska kalkyler (Socio-economic calculations).

12.

11. Measles surveillance: Center for Disease Control. Report no 9, 1972, Summary. Atlanta, 1973.

13.

12. Measles vaccination: Report of a working group. Algiers, April 15-29, 1972. Copenhagen, 1972.

14.

13. Miller, D. L. :Frequences of complications of measles, 1963. Report on a national inquiry of the Public Health Laboratory Service in collaboration with the Society of Medical Officers of Health. Br Med J 2: 75, 1964.

15.

14. Niemelä, P. , Laurinkari, J. , Elo. O. & Ekblom, M. :Tuhkarokkorokotuksen Suomessa aiheuttamat kustannukset sekä rokotuksesta koituvat hyödyt (Costs induced by measles vaccination in Finland and benefits gained from vaccination). Sosiaalilääketieteellinen Aikakauslehti 12: 605, 1975.

16.

15. Niemelä, P. , Laurinkari, J. & Elo, O. :Vihurirokon aiheuttamat taloudelliset menetykset (Economical losses due to rubella). Sosiaalilääketieteellinen Aikakakauslehti 11: 19, 1974.

17.

16. Prest, A. A. & Turvey. R. :Cost-benefit analysis: a survey. The Economic Journal 75: 686, 1965.

18.

17. Pätiälä, H. , Niemelä, P. & Laurinkari, J. :Polvisyno-vektomialeikkausten kustannushyötyanalyyttinen tarkastelu. Sosiaalilääketieteellinen Aikakauslehti 12: 493, 1975. (Cost-benefit analytical survey of synovectomies of the knee.)

19.

18. Remedia Fennica 1975: Edited by Olli P. Heinonen, Helsinki, 1974.

20.

19. Ruuskanen, O., Salmi, T. T. & Halonen, P.: Suomessa käytetyn tuhkarokkorokotteen rokotusreaktiot ja sen aikaansaama vasta-aineiden muodostus (Vaccination Reactions caused by Measles Vaccine used in Finland and Antibody Formation). Suomen Lää-kärilehti 1975.

21.

20. Ström, J. :Mortalitet och morbiditet vid mässling (Mortality and morbidity of measles). Läkartidningen 64: 1096, 1967.

22.

21. Ström, J.: Akuta infektionssjukdomar (Acute infectious diseases). Lund, 1971.

23.

22. Suomen Sairaalatalous 1974: Sairaalaliitto. Vol. 12. Helsinki, 1975. (Finnish Hospital Economy 1974: Hospital League. Vol. 12. Helsinki 1975.)

24.

23. Vahlquist, B. :Landsomfattande kampanj bör förberedas (A national campaign should be prepared). Läkartidningen 65: 4910, 1968.

25.

24. Witte, J. J. & Axnick, N. W. :The benefits from 10 years of measles immunization in the United States. Public Health Report 90: 205, 1975.

26.

25. Communal Population prognosis 1975-2010. VA: 12. Central Office of Statistics, Helsinki, 1975.

27.

26. Mortality and Survival Rate Index 1972: VA 9. Statistical Information, Helsinki, 1975.

28.

27. Mortality Statistics during 1963-1973. Central Office of Statistics, Helsinki.

29.

28. Yleissairaaloista poistetut diagnoosiryhmittäin vuosina 1972-1973: Lääkintöhallitus, Helsinki. (Dismissals from general hospitals by diagnosis categories in 1972-1973, National Board of Health, diagrams.)